{"nctId":"NCT00092521","briefTitle":"Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)","startDateStruct":{"date":"2001-12"},"conditions":["Cervical Cancer","Genital Warts"],"count":5759,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Biological: V501"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Comparator: Placebo"]},{"label":"3","type":"EXPERIMENTAL","interventionNames":["Biological: Human Papillomavirus (HPV) 16 Monovalent"]}],"interventions":[{"name":"V501","otherNames":[]},{"name":"Comparator: Placebo","otherNames":[]},{"name":"Human Papillomavirus (HPV) 16 Monovalent","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Female with an intact uterus with lifetime history of 0-4 sexual partners\n\nExclusion Criteria:\n\n* Prior Human Papillomavirus (HPV) vaccination\n* Prior abnormal paps\n* History of genital warts","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"16 Years","maximumAge":"23 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Incidence of HPV 6/11/16/18-related Cervical Intraepithelial Neoplasia (CIN)(Any Grade), Adenocarcinoma In Situ (AIS) or Cervical Cancer","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1.2","spread":null}]}]}]},{"type":"PRIMARY","title":"Incidence of HPV 6/11/16/18-related External Genital Lesions (EGL) [Genital Warts, Vulvar/Vaginal Intraepithelial Neoplasia (Any Grade), Vulvar/Vaginal Cancer]","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1.1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":50,"n":2673},"commonTop":["Injection site pain","Injection site erythema","Injection site swelling","Headache","Pyrexia"]}}}